Charles Q. Morris, M.D.
Equibles does not estimate personal net worth.
Get an email with a short summary when Prelude Therapeutics Inc publishes a filing, an earnings call transcript or a press release.
Get PRLD alertsAbout Charles Q. Morris, M.D.
Prelude Therapeutics Inc reported in an 8-K filed April 15, 2026 that Charles Q. Morris, M.D. was appointed Chief Medical Officer, effective April 20, 2026. Prelude Therapeutics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Prelude Therapeutics Inc includes Krishna Vaddi (CEO and Board Member), Bryant D. Lim (CFO), Julian C. Baker (Board Member) and 3 others.
“On April 15, 2026 Prelude Therapeutics Incorporated, (the "Company") announced that the Board of Directors of the Company (the "Board") appointed Charles Q. Morris, M.D., age 61, as the Chief Medical Officer of the Company, effective on April 20, 2026 (the "Appointment Date").”
Affiliation history
-
Prelude Therapeutics Inc (PRLD)
SEC 8-K
Current2026-04-20–present
Company network
Leadership on record at Prelude Therapeutics Inc
- Krishna Vaddi CEO, Board Member
- Bryant D. Lim CFO
- Julian C. Baker Board Member
- Katina Dorton Board Member
- Martin Babler Board Member
- Paul Scherer, M.D. Board Member